215 related articles for article (PubMed ID: 30586744)
1. Chronic Calmodulin-Kinase II Activation Drives Disease Progression in Mutation-Specific Hypertrophic Cardiomyopathy.
Lehman SJ; Tal-Grinspan L; Lynn ML; Strom J; Benitez GE; Anderson ME; Tardiff JC
Circulation; 2019 Mar; 139(12):1517-1529. PubMed ID: 30586744
[TBL] [Abstract][Full Text] [Related]
2. Hypertrophic cardiomyopathy mutations increase myofilament Ca
Robinson P; Liu X; Sparrow A; Patel S; Zhang YH; Casadei B; Watkins H; Redwood C
J Biol Chem; 2018 Jul; 293(27):10487-10499. PubMed ID: 29760186
[TBL] [Abstract][Full Text] [Related]
3. Temporal and mutation-specific alterations in Ca2+ homeostasis differentially determine the progression of cTnT-related cardiomyopathies in murine models.
Guinto PJ; Haim TE; Dowell-Martino CC; Sibinga N; Tardiff JC
Am J Physiol Heart Circ Physiol; 2009 Aug; 297(2):H614-26. PubMed ID: 19502551
[TBL] [Abstract][Full Text] [Related]
4. Genotype-Dependent and -Independent Calcium Signaling Dysregulation in Human Hypertrophic Cardiomyopathy.
Helms AS; Alvarado FJ; Yob J; Tang VT; Pagani F; Russell MW; Valdivia HH; Day SM
Circulation; 2016 Nov; 134(22):1738-1748. PubMed ID: 27688314
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis of Hypertrophic Cardiomyopathy is Mutation Rather Than Disease Specific: A Comparison of the Cardiac Troponin T E163R and R92Q Mouse Models.
Ferrantini C; Coppini R; Pioner JM; Gentile F; Tosi B; Mazzoni L; Scellini B; Piroddi N; Laurino A; Santini L; Spinelli V; Sacconi L; De Tombe P; Moore R; Tardiff J; Mugelli A; Olivotto I; Cerbai E; Tesi C; Poggesi C
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28735292
[TBL] [Abstract][Full Text] [Related]
6. Dilated cardiomyopathy mutations in thin-filament regulatory proteins reduce contractility, suppress systolic Ca
Robinson P; Sparrow AJ; Patel S; Malinowska M; Reilly SN; Zhang YH; Casadei B; Watkins H; Redwood C
Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H306-H319. PubMed ID: 32618513
[TBL] [Abstract][Full Text] [Related]
7. Desensitization of myofilaments to Ca2+ as a therapeutic target for hypertrophic cardiomyopathy with mutations in thin filament proteins.
Alves ML; Dias FAL; Gaffin RD; Simon JN; Montminy EM; Biesiadecki BJ; Hinken AC; Warren CM; Utter MS; Davis RT; Sakthivel S; Robbins J; Wieczorek DF; Solaro RJ; Wolska BM
Circ Cardiovasc Genet; 2014 Apr; 7(2):132-143. PubMed ID: 24585742
[TBL] [Abstract][Full Text] [Related]
8. Ranolazine Prevents Phenotype Development in a Mouse Model of Hypertrophic Cardiomyopathy.
Coppini R; Mazzoni L; Ferrantini C; Gentile F; Pioner JM; Laurino A; Santini L; Bargelli V; Rotellini M; Bartolucci G; Crocini C; Sacconi L; Tesi C; Belardinelli L; Tardiff J; Mugelli A; Olivotto I; Cerbai E; Poggesi C
Circ Heart Fail; 2017 Mar; 10(3):. PubMed ID: 28255011
[TBL] [Abstract][Full Text] [Related]
9. CaMKII-mediated phosphorylation of RyR2 plays a crucial role in aberrant Ca
Okuda S; Sufu-Shimizu Y; Kato T; Fukuda M; Nishimura S; Oda T; Kobayashi S; Yamamoto T; Morimoto S; Yano M
Biochem Biophys Res Commun; 2018 Feb; 496(4):1250-1256. PubMed ID: 29402414
[TBL] [Abstract][Full Text] [Related]
10. Calcium-calmodulin-dependent protein kinase mediates the intracellular signalling pathways of cardiac apoptosis in mice with impaired glucose tolerance.
Federico M; Portiansky EL; Sommese L; Alvarado FJ; Blanco PG; Zanuzzi CN; Dedman J; Kaetzel M; Wehrens XHT; Mattiazzi A; Palomeque J
J Physiol; 2017 Jun; 595(12):4089-4108. PubMed ID: 28105734
[TBL] [Abstract][Full Text] [Related]
11. Autonomous activation of CaMKII exacerbates diastolic calcium leak during beta-adrenergic stimulation in cardiomyocytes of metabolic syndrome rats.
Romero-García T; Landa-Galvan HV; Pavón N; Mercado-Morales M; Valdivia HH; Rueda A
Cell Calcium; 2020 Nov; 91():102267. PubMed ID: 32920522
[TBL] [Abstract][Full Text] [Related]
12. Differential control of calcium homeostasis and vascular reactivity by Ca2+/calmodulin-dependent kinase II.
Prasad AM; Nuno DW; Koval OM; Ketsawatsomkron P; Li W; Li H; Shen FY; Joiner ML; Kutschke W; Weiss RM; Sigmund CD; Anderson ME; Lamping KG; Grumbach IM
Hypertension; 2013 Aug; 62(2):434-41. PubMed ID: 23753415
[TBL] [Abstract][Full Text] [Related]
13. Blocking cardiac growth in hypertrophic cardiomyopathy induces cardiac dysfunction and decreased survival only in males.
Luckey SW; Mansoori J; Fair K; Antos CL; Olson EN; Leinwand LA
Am J Physiol Heart Circ Physiol; 2007 Feb; 292(2):H838-45. PubMed ID: 17012357
[TBL] [Abstract][Full Text] [Related]
14. HCM-linked ∆160E cardiac troponin T mutation causes unique progressive structural and molecular ventricular remodeling in transgenic mice.
Moore RK; Grinspan LT; Jimenez J; Guinto PJ; Ertz-Berger B; Tardiff JC
J Mol Cell Cardiol; 2013 May; 58():188-98. PubMed ID: 23434821
[TBL] [Abstract][Full Text] [Related]
15. AKAP18δ Anchors and Regulates CaMKII Activity at Phospholamban-SERCA2 and RYR.
Carlson CR; Aronsen JM; Bergan-Dahl A; Moutty MC; Lunde M; Lunde PK; Jarstadmarken H; Wanichawan P; Pereira L; Kolstad TRS; Dalhus B; Subramanian H; Hille S; Christensen G; Müller OJ; Nikolaev V; Bers DM; Sjaastad I; Shen X; Louch WE; Klussmann E; Sejersted OM
Circ Res; 2022 Jan; 130(1):27-44. PubMed ID: 34814703
[TBL] [Abstract][Full Text] [Related]
16. Ca2+/calmodulin-dependent protein kinase modulates cardiac ryanodine receptor phosphorylation and sarcoplasmic reticulum Ca2+ leak in heart failure.
Ai X; Curran JW; Shannon TR; Bers DM; Pogwizd SM
Circ Res; 2005 Dec; 97(12):1314-22. PubMed ID: 16269653
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of phospholamban and Ca2+/calmodulin-dependent kinase II on [Ca2+]i transients in cardiac myocytes at physiological stimulation frequencies.
Werdich AA; Lima EA; Dzhura I; Singh MV; Li J; Anderson ME; Baudenbacher FJ
Am J Physiol Heart Circ Physiol; 2008 May; 294(5):H2352-62. PubMed ID: 18359893
[TBL] [Abstract][Full Text] [Related]
18. Sexually dimorphic myofilament function and cardiac troponin I phosphospecies distribution in hypertrophic cardiomyopathy mice.
McKee LA; Chen H; Regan JA; Behunin SM; Walker JW; Walker JS; Konhilas JP
Arch Biochem Biophys; 2013 Jul; 535(1):39-48. PubMed ID: 23352598
[TBL] [Abstract][Full Text] [Related]
19. Increase in tension-dependent ATP consumption induced by cardiac troponin T mutation.
Chandra M; Tschirgi ML; Tardiff JC
Am J Physiol Heart Circ Physiol; 2005 Nov; 289(5):H2112-9. PubMed ID: 15994854
[TBL] [Abstract][Full Text] [Related]
20. Calcium/calmodulin-dependent kinase II and nitric oxide synthase 1-dependent modulation of ryanodine receptors during β-adrenergic stimulation is restricted to the dyadic cleft.
Dries E; Santiago DJ; Johnson DM; Gilbert G; Holemans P; Korte SM; Roderick HL; Sipido KR
J Physiol; 2016 Oct; 594(20):5923-5939. PubMed ID: 27121757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
